Sotera Health chair sells 1.14M shares at $18.50
Sotera Health Co (SHC) reported that Executive Chairman Michael B. Petras Jr. sold shares of common stock on August 17, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Sotera Health Co (SHC) reported that Executive Chairman Michael B. Petras Jr. sold shares of common stock on August 17, 2026. He sold 294,515 shares held directly and 850,000 shares held indirectly through a grantor trust at an average weighted price of $18.5011 per share, with trade prices ranging from $18.50 to $18.855. Following these transactions, he holds 397,912 shares directly and 3,969,393 shares indirectly through the grantor trust.
Insider Trade Summary
Net Seller: 1,144,515 shares
Net Sell
2 txns
Insider
Petras Michael B. Jr.
Role
Executive Chairman
Sold
1,144,515 shs ($21.17M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $0.01 par value per share ("Common Stock") F1 | 294,515 | $18.5011 | $5.45M |
| Sale | Common Stock F2 | 850,000 | $18.5011 | $15.73M |
Holdings After Transaction:
Common Stock, $0.01 par value per share ("Common Stock") — 397,912 shares (Direct);
Common Stock — 3,969,393 shares (Indirect, By Grantor Trust)
Footnotes (2)
- F1. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Key Figures
Direct shares sold: 294,515 shares
Indirect shares sold: 850,000 shares
Total shares sold: 1,144,515 shares
+5 more
8 metrics
Direct shares sold
294,515 shares
Common Stock sale on August 17, 2026, by Executive Chairman (direct ownership)
Indirect shares sold
850,000 shares
Common Stock sale on August 17, 2026, via Grantor Trust (indirect ownership)
Total shares sold
1,144,515 shares
Aggregate net sell shares in transaction summary
Average sale price
$18.5011 per share
Weighted average price for both reported sales, subject to stated price range
Sale price range low
$18.50
Lowest price in the stated sale range for the August 17, 2026 transactions
Sale price range high
$18.855
Highest price in the stated sale range for the August 17, 2026 transactions
Direct holdings after sale
397,912 shares
Direct common stock owned by Michael B. Petras Jr. following the sale
Indirect holdings after sale
3,969,393 shares
Indirect common stock holdings via Grantor Trust following the sale
Key Terms
Grantor Trust, average weighted price, Power of Attorney
3 terms
Grantor Trust financial
"Indirect ownership is reported as "By Grantor Trust" for certain shares."
A grantor trust is a legal arrangement where the person who puts assets into the trust keeps enough control or rights that, for tax and legal purposes, those assets are treated as still belonging to that person. For investors, that matters because income, gains and losses generated by the trust typically flow through to the grantor (or directly to investors) for tax reporting and distributions, affecting after-tax returns and cash flow predictability — think of it like a mailbox that forwards all the mail back to the sender rather than holding it inside.
average weighted price financial
"Price reported constitutes the average weighted price of shares sold."
Power of Attorney regulatory
"Remarks reference "Exhibit 24.1 - Power of Attorney" for the filer."
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did SHC report for Michael B. Petras Jr. on August 17, 2026?
On August 17, 2026, Michael B. Petras Jr. reported selling 294,515 SHC shares held directly and 850,000 shares held indirectly through a grantor trust. All transactions involved common stock of Sotera Health Co.
What are Michael B. Petras Jr.’s remaining SHC holdings after these sales?
After the reported sales, Michael B. Petras Jr. holds 397,912 SHC shares directly and 3,969,393 shares indirectly via a grantor trust. These post-transaction balances are stated in the non-derivative transaction entries for direct and indirect ownership.
Were the August 17, 2026 SHC insider sales under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirming plan status. There is no footnote indicating that these particular SHC share sales were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates